Prevalence and Management of Diabetic Nephropathy in Western Countries.
about
Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus.Sodium-Glucose Cotransporter 2 Inhibitors with Renoprotective Effects.Dietary Approaches in the Management of Diabetic Patients with Kidney Disease.GS-E3D, a new pectin lyase-modified red ginseng extract, inhibited diabetes-related renal dysfunction in streptozotocin-induced diabetic rats.Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion.Tubulointerstitial Biomarkers for Diabetic Nephropathy.
P2860
Prevalence and Management of Diabetic Nephropathy in Western Countries.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevalence and Management of Diabetic Nephropathy in Western Countries.
@en
Prevalence and Management of Diabetic Nephropathy in Western Countries.
@nl
type
label
Prevalence and Management of Diabetic Nephropathy in Western Countries.
@en
Prevalence and Management of Diabetic Nephropathy in Western Countries.
@nl
prefLabel
Prevalence and Management of Diabetic Nephropathy in Western Countries.
@en
Prevalence and Management of Diabetic Nephropathy in Western Countries.
@nl
P2860
P356
P1476
Prevalence and Management of Diabetic Nephropathy in Western Countries.
@en
P2093
Bancha Satirapoj
Sharon G Adler
P2860
P356
10.1159/000382028
P577
2015-05-01T00:00:00Z